FOR IMMEDIATE RELEASE Groundbreaking Global Study Establishes First International Benchmark Framework for Pediatric Liver Transplantation Bridge to Life highlights study presented as oral late-breaking clinical trial during “The 2026 International Congress of
FOR IMMEDIATE RELEASE Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment Studies
Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026 Presentations to highlight hypothermic oxygenated perfusion
New Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation Research was shared during an oral session at
FOR IMMEDIATE RELEASE Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025 Pivotal Findings Spotlighted in Plenary Session, Late-Breaking Presentations, and Symposium on Next-Gen Liver
Bridge to Life CEO Don Webber Shares HOPE Breakthrough with Transplant Community at WTC 2025 To the Organ Transplantation Community, What an incredible week it was for Bridge to Life at the World
FOR IMMEDIATE RELEASE New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation Presentations showcased at World Transplant Congress in
Abstracts to highlight hypothermic oxygenated perfusion (HOPE) in liver transplants, including pediatric patients Chicago, May 15, 2025 Bridge to Life™ Ltd., a leader in organ preservation solutions and perfusion technology, today announced the
FOR IMMEDIATE RELEASE First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE New data presented during Plenary Session at
Ownership Strengthens Bridge to Life's Position in Organ Preservation and Solidifies Enterprise Value Chicago, December 18, 2024 – Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has
Chicago, November 14, 2024 – Bridge to Life Ltd., a leading provider of organ preservation solutions and organ perfusion equipment, has announced that more than 5,0001 liver perfusions worldwide have
At the 2024 ELITA Summit, an Italian study showcased remarkable advancements in liver transplantation, challenging long-standing perceptions of marginal donor organs. Led by Dr. Matteo Ravaioli and his team from
